US EditionBioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as ...
Summary by Weatherford Democrat
6 Articles
6 Articles
All
Left
1
Center
1
Right
1
Weatherford DemocratReposted by 
The Batesville Daily Guard
The Batesville Daily GuardBioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide,…
Coverage Details
Total News Sources6
Leaning Left1Leaning Right1Center1Last UpdatedBias Distribution33% Left, 33% Center, 33% Right
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
33% Right
L 33%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
